Ascendis Pharma A/S ADR | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
27,094.00
18,547.70
9,002.20
5,095.10
1,725.70
12,482.90
SG&A Expense
19,547.90
33,781.90
54,764.10
85,010.10
126,708.70
194,019.30
EBIT
7,008.50
15,902.80
46,380.60
80,663.90
125,810.90
182,574.60
Non Operating Income/Expense
751.40
2,187.30
9,135.30
4,496.70
15,515.90
24,263.90
Interest Expense
10.60
-
-
-
-
-
Pretax Income
6,246.40
13,715.40
37,230.90
76,031.10
140,285.70
153,568.10
Income Tax
831.10
904.60
723.00
251.10
538.00
464.80
Consolidated Net Income
5,415.40
12,810.80
36,507.90
75,780.00
139,747.60
153,481.90
Net Income
5,415.40
12,810.80
36,507.90
75,780.00
139,747.60
153,481.90
Net Income After Extraordinaries
5,415.40
12,810.80
36,507.90
75,780.00
139,747.60
153,481.90
Net Income Available to Common
5,415.40
12,810.80
36,507.90
75,780.00
139,747.60
153,481.90
EPS (Basic)
0.23
0.54
-
2.85
4.15
3.74
Basic Shares Outstanding
23,835.80
23,835.80
23,766.80
26,564.40
33,626.30
41,085.20
EPS (Diluted)
0.23
0.54
1.54
2.85
4.16
3.74
Diluted Shares Outstanding
23,835.80
23,835.80
23,766.80
26,564.40
33,626.30
41,085.20
EBITDA
7,546.20
15,234.20
45,761.90
79,915.00
124,983.00
181,536.40
Non-Operating Interest Income
-
-
14.40
136.10
1,041.10
4,742.60
About Ascendis Pharma A/S
View Profile
